Safety of primed repetitive transcranial magnetic stimulation and modified constraint-induced movement therapy in a randomized controlled trial in pediatric hemiparesis.
Safety of primed repetitive transcranial magnetic stimulation and modified constraint-induced movement therapy in a randomized controlled trial in pediatric hemiparesis.
复制标题
DOI:
10.1016/j.apmr.2014.09.012
复制
发表时间:
2015-04
影响因子:
4.3
通讯作者:
Carey, James R.
中科院分区:
文献类型:
--
作者:
Gillick, Bernadette T.;Krach, Linda E.;Feyma, Tim;Rich, Tonya L.;Moberg, Kelli;Menk, Jeremiah;Cassidy, Jessica;Kimberley, Teresa;Carey, James R.
To investigate the safety of combining 6-Hz primed low-frequency repetitive transcranial magnetic stimulation (rTMS) intervention in the contralesional hemisphere with a modified constraint-induced movement therapy (mCIMT) program in children with congenital hemiparesis. Phase 1 randomized, double-blinded, placebo-controlled pretest/posttest trial. University academic facility and a pediatric specialty hospital. Nineteen subjects aged 8 to 17 years with congenital hemiparesis due to ischemic stroke or periventricular leukomalacia. No subject withdrew due to adverse events. All subjects included completed the study. Subjects were randomized to one of two groups: either rTMSreal with mCIMT (n = 10) or rTMSsham with mCIMT (n = 9). Adverse events, physician assessment, ipsilateral hand function, stereognosis, cognitive function, subject report of symptoms assessment and subject questionnaire. No major adverse events occurred. Minor adverse events were found in both groups. The most common were headaches (real: 50%, sham: 89%, p=0.14) and cast irritation (real: 30%, sham: 44%, p = 0.65). No differences between groups in secondary cognitive and unaffected hand motor measures were found. Primed rTMS can be used safely with mCIMT in congenital hemiparesis. We provide new information on the use of rTMS in combination with mCIMT in children. These findings could be useful in research and future clinical applications in advancing function in congenital hemiparesis.
登录
查看更多内容
影响因子:
4.2
作者:
Carey, James R.;Evans, Chad D.;Pascual-Leone, Alvaro
通讯作者:
Pascual-Leone, Alvaro
影响因子:
48
作者:
Kirton, Adam;Chen, Robert;deVeber, Gabrielle
通讯作者:
deVeber, Gabrielle
影响因子:
1.9
作者:
Kakuda, Wataru;Abo, Masahiro;Umemori, Takuma
通讯作者:
Umemori, Takuma
影响因子:
5.3
作者:
Gersner, Roman;Kravetz, Elena;Zangen, Abraham
通讯作者:
Zangen, Abraham
影响因子:
3.8
作者:
Kirton, Adam;deVeber, Gabrielle;Chen, Robert
通讯作者:
Chen, Robert